Dr. Per Spindler is Director of Biopeople – Denmark’s Life Science Cluster - at University of Copenhagen since 2005. Biopeople was the first European cluster organization within health and life sciences to receive the recognition of Gold Label of the European Cluster Excellence Initiative (ECEI). Before, he has industrial work experience from scientific and managerial positions at H. Lundbeck A/S, Novo Nordisk A/S and latest as Vice President at BioImage A/S, a spin-off from Novo Nordisk A/S. Dr. Spindler has a medicines regulatory background from the Danish Medicines Agency and the scientific committees of the European Medicines Agency. Dr. Spindler holds a DVM from University of Copenhagen, an Executive MBA from the Copenhagen Business School Executive (SIMI), and an MSc in Applied Toxicology from University of Surrey. Dr. Spindler is European Registered Toxicologist (ERT). Dr. Spindler received the DIA Outstanding Service Award in 2002, and he is currently President and Chairman of the Board of the Drug Information Association (DIA).